Research and Development Unit, Shamir Medical Center, Zerifin, Israel.
The Sagol Center for Hyperbaric Medicine and Research, Shamir (Assaf-Harofeh) Medical Center, Zerifin, Israel.
Aging (Albany NY). 2020 Nov 18;12(22):22445-22456. doi: 10.18632/aging.202188.
Aging is characterized by the progressive loss of physiological capacity. At the cellular level, two key hallmarks of the aging process include telomere length (TL) shortening and cellular senescence. Repeated intermittent hyperoxic exposures, using certain hyperbaric oxygen therapy (HBOT) protocols, can induce regenerative effects which normally occur during hypoxia. The aim of the current study was to evaluate whether HBOT affects TL and senescent cell concentrations in a normal, non-pathological, aging adult population.
Thirty-five healthy independently living adults, aged 64 and older, were enrolled to receive 60 daily HBOT exposures. Whole blood samples were collected at baseline, at the 30 and 60 session, and 1-2 weeks following the last HBOT session. Peripheral blood mononuclear cells (PBMCs) telomeres length and senescence were assessed.
Telomeres length of T helper, T cytotoxic, natural killer and B cells increased significantly by over 20% following HBOT. The most significant change was noticed in B cells which increased at the 30 session, 60 session and post HBOT by 25.68%±40.42 (p=0.007), 29.39%±23.39 (p=0.0001) and 37.63%±52.73 (p=0.007), respectively. There was a significant decrease in the number of senescent T helpers by -37.30%±33.04 post-HBOT (P<0.0001). T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. In conclusion, the study indicates that HBOT may induce significant senolytic effects including significantly increasing telomere length and clearance of senescent cells in the aging populations.
衰老是生理机能逐渐丧失的特征。在细胞水平上,衰老过程的两个关键标志包括端粒长度(TL)缩短和细胞衰老。使用某些高压氧治疗(HBOT)方案进行重复间歇性高氧暴露,可以诱导正常缺氧时发生的再生效应。本研究旨在评估 HBOT 是否会影响正常、非病理、衰老成人人群的 TL 和衰老细胞浓度。
招募了 35 名年龄在 64 岁及以上、独立生活的健康成年人,接受 60 次每日 HBOT 暴露。在基线、第 30 次和第 60 次治疗以及最后一次 HBOT 治疗后 1-2 周采集全血样本。评估外周血单核细胞(PBMC)端粒长度和衰老情况。
HBOT 后,辅助性 T 细胞、细胞毒性 T 细胞、自然杀伤细胞和 B 细胞的端粒长度显著增加超过 20%。B 细胞的变化最为显著,在第 30 次、第 60 次和 HBOT 后分别增加了 25.68%±40.42(p=0.007)、29.39%±23.39(p=0.0001)和 37.63%±52.73(p=0.007)。HBOT 后,衰老的辅助性 T 细胞数量显著减少了-37.30%±33.04(P<0.0001)。细胞毒性 T 细胞衰老细胞的百分比显著减少了-10.96%±12.59(p=0.0004)。总之,该研究表明,HBOT 可能诱导显著的衰老细胞清除作用,包括显著增加端粒长度和衰老细胞清除。